Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
Bardhan, K D
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. [electronic resource] - BMJ (Clinical research ed.) Feb 1999 - 502-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0959-8138
10.1136/bmj.318.7182.502 doi
Adult
Aged
Anti-Ulcer Agents--therapeutic use
Double-Blind Method
Female
Gastroesophageal Reflux--drug therapy
Humans
Male
Middle Aged
Omeprazole--therapeutic use
Ranitidine--therapeutic use
Time Factors
Treatment Outcome
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group. [electronic resource] - BMJ (Clinical research ed.) Feb 1999 - 502-7 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0959-8138
10.1136/bmj.318.7182.502 doi
Adult
Aged
Anti-Ulcer Agents--therapeutic use
Double-Blind Method
Female
Gastroesophageal Reflux--drug therapy
Humans
Male
Middle Aged
Omeprazole--therapeutic use
Ranitidine--therapeutic use
Time Factors
Treatment Outcome